Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murielle Roussel

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Blood|January 3, 2020
Crowded bone marrow plasma cellsJill Corre, Murielle Roussel
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Maintenance therapy for myeloma: how much, how long, and at what cost?Michel Attal, Murielle Roussel
European Journal of Haematology|November 6, 2015
'Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury'Stanislas Faguer, Murielle Roussel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survivalAntonio Palumbo, Michel Attal, Murielle Roussel
Cell Death and Differentiation|April 15, 2025
CD95/Fas stoichiometry in future precision medicineMauricio Sica, Murielle Roussel, Patrick Legembre
La Revue Du Praticien|March 15, 2019
[Multiple myeloma treatment]Alexis Talbot, Bruno Royer, Murielle Roussel
La Revue Du Praticien|November 10, 2009
[Multiple bone myelomas]Murielle Roussel, Thomas Gastinne, Xavier Leleu
Presse Medicale (Paris, France : 1983)|January 23, 2025
POEMS SyndromeArnaud Jaccard, Virginie Pascal, Laurent Magy, et al.
Clinical Nephrology|September 18, 2013
An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosisJoelle Guitard, Celine Guilbeau-Frugier, Murielle Roussel, et al.
Leukemia & Lymphoma|June 14, 2021
Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation who received lenalidomide- or bortezomib-based regimensElena Zamagni, Sujith Dhanasiri, Arun Ghale, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Blood|January 3, 2020
Crowded bone marrow plasma cellsJill Corre, Murielle Roussel
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Maintenance therapy for myeloma: how much, how long, and at what cost?Michel Attal, Murielle Roussel
European Journal of Haematology|November 6, 2015
'Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury'Stanislas Faguer, Murielle Roussel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survivalAntonio Palumbo, Michel Attal, Murielle Roussel
Cell Death and Differentiation|April 15, 2025
CD95/Fas stoichiometry in future precision medicineMauricio Sica, Murielle Roussel, Patrick Legembre
La Revue Du Praticien|March 15, 2019
[Multiple myeloma treatment]Alexis Talbot, Bruno Royer, Murielle Roussel
La Revue Du Praticien|November 10, 2009
[Multiple bone myelomas]Murielle Roussel, Thomas Gastinne, Xavier Leleu
Presse Medicale (Paris, France : 1983)|January 23, 2025
POEMS SyndromeArnaud Jaccard, Virginie Pascal, Laurent Magy, et al.
Clinical Nephrology|September 18, 2013
An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosisJoelle Guitard, Celine Guilbeau-Frugier, Murielle Roussel, et al.
Leukemia & Lymphoma|June 14, 2021
Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation who received lenalidomide- or bortezomib-based regimensElena Zamagni, Sujith Dhanasiri, Arun Ghale, et al.
Pageof 10